Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
QXO, Inc. (QXO), a distributor of roofing, waterproofing and complementary building products, was a bottom contributor during the second quarter. Following our entry...
— TimesSquare Capital Management LLC
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on QXO, Inc.
One such stock was building products distributor QXO, which proved to be a detractor for the quarter. We initiated our...
Added in April, QXO fell after announcing its acquisition of TopBuild due to market concerns over leverage and integration. However, the manager...
QXO (QXO) shares underperformed during the period as investors remained focused on near-term macroeconomic headwinds, including a sluggish U.S. housing market and persistently elevated interest rates,
More institutional theses from TimesSquare Capital Management U.S. Mid Cap Growth Strategy
CG Oncology Inc. is a late-stage clinical biopharmaceutical company focused on developing therapeutics to treat bladder cancer.
Lattice Semiconductor Corp. develops semiconductor, silicon-based, silicon-enabled products including programmable gate arrays. A solid quarter...